| Q42540847 | Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? |
| Q24644642 | Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals |
| Q37075592 | Corporate influences on epidemiology |
| Q52305118 | Inaccuracies in editorial by Babor & Miller. |
| Q37246642 | Industry funding and the reporting quality of large long-term weight loss trials. |
| Q28748748 | JAMA published fewer industry-funded studies after introducing a requirement for independent statistical analysis |
| Q43167119 | JAMA's policy on industry sponsored studies |
| Q58671322 | Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine" |
| Q34036715 | Taking financial relationships into account when assessing research |
| Q56602002 | The Problem of Biased Data and Potential Solutions for Health and Environmental Assessments |
| Q48703134 | The potential for bias in reporting of industry-sponsored clinical trials |
| Q85156629 | Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research |